Cutaneous Oncology News

Patients with metastatic melanoma who underwent treatment with immunotherapy derived a benefit when they also received beta blockers, according to study results.

The American Academy of Dermatology published guidelines for the management of nonmelanoma skin cancer.

An educational video significantly improved hairdressers’ knowledge of melanoma warning signs and their confidence in their ability to identify potentially cancerous skin lesions, according to study results.

Among 11 patients with vulval lichen planus who achieved disease remission, nine were treated primarily by a dermatologist.

The FDA granted priority review to mogamulizumab for the treatment of patients with cutaneous T-cell lymphoma who underwent at least one prior systemic therapy, according to the agent’s manufacturer.

A diagnosis of melanocytic proliferation was reported in almost 25% of skin biopsies, according to results of a large population-based study.

The FDA has granted breakthrough therapy designation and orphan drug designation to topical patidegib for the treatment of basal cell carcinoma nevus syndrome, which is also known as Gorlin syndrome, according to a press release from PellePharm.

Squamous cell carcinoma was associated with a 25% increase in all-cause mortality compared with patients in the general population.

The combination of an oncolytic virus plus a checkpoint inhibitor improved survival among patients with advanced melanoma compared with monotherapy, according to data from a phase 2 study published in Journal of Clinical Oncology.

Although immunosuppression associated with multiple myeloma may not predispose patients to melanoma, other immunosuppressed states may increase melanoma risk, according to recent findings.